Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000685871 | SCV000813371 | likely benign | Hereditary insensitivity to pain with anhidrosis | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002406534 | SCV002717421 | uncertain significance | Inborn genetic diseases | 2023-05-16 | criteria provided, single submitter | clinical testing | The c.1921G>T (p.V641L) alteration is located in exon 14 (coding exon 14) of the NTRK1 gene. This alteration results from a G to T substitution at nucleotide position 1921, causing the valine (V) at amino acid position 641 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV003884703 | SCV004700966 | uncertain significance | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | NTRK1: PM2, PP3 |
Natera, |
RCV000685871 | SCV001463409 | uncertain significance | Hereditary insensitivity to pain with anhidrosis | 2020-04-18 | no assertion criteria provided | clinical testing |